269 related articles for article (PubMed ID: 30912016)
1. In Silico Target Druggability Assessment: From Structural to Systemic Approaches.
Trosset JY; Cavé C
Methods Mol Biol; 2019; 1953():63-88. PubMed ID: 30912016
[TBL] [Abstract][Full Text] [Related]
2. Structure-based target druggability assessment.
Trosset JY; Vodovar N
Methods Mol Biol; 2013; 986():141-64. PubMed ID: 23436411
[TBL] [Abstract][Full Text] [Related]
3. In silico structure-based approaches to discover protein-protein interaction-targeting drugs.
Shin WH; Christoffer CW; Kihara D
Methods; 2017 Dec; 131():22-32. PubMed ID: 28802714
[TBL] [Abstract][Full Text] [Related]
4. Improving small molecule virtual screening strategies for the next generation of therapeutics.
Wingert BM; Camacho CJ
Curr Opin Chem Biol; 2018 Jun; 44():87-92. PubMed ID: 29920436
[TBL] [Abstract][Full Text] [Related]
5. Applications of the NRGsuite and the Molecular Docking Software FlexAID in Computational Drug Discovery and Design.
Morency LP; Gaudreault F; Najmanovich R
Methods Mol Biol; 2018; 1762():367-388. PubMed ID: 29594781
[TBL] [Abstract][Full Text] [Related]
6. Binding site druggability assessment in fragment-based drug design.
Zhou Y; Huang N
Methods Mol Biol; 2015; 1289():13-21. PubMed ID: 25709029
[TBL] [Abstract][Full Text] [Related]
7. New approaches for computing ligand-receptor binding kinetics.
Bruce NJ; Ganotra GK; Kokh DB; Sadiq SK; Wade RC
Curr Opin Struct Biol; 2018 Apr; 49():1-10. PubMed ID: 29132080
[TBL] [Abstract][Full Text] [Related]
8. New Frontiers in Druggability.
Kozakov D; Hall DR; Napoleon RL; Yueh C; Whitty A; Vajda S
J Med Chem; 2015 Dec; 58(23):9063-88. PubMed ID: 26230724
[TBL] [Abstract][Full Text] [Related]
9. Form follows function: shape analysis of protein cavities for receptor-based drug design.
Weisel M; Proschak E; Kriegl JM; Schneider G
Proteomics; 2009 Jan; 9(2):451-9. PubMed ID: 19142949
[TBL] [Abstract][Full Text] [Related]
10. Cryptic binding sites on proteins: definition, detection, and druggability.
Vajda S; Beglov D; Wakefield AE; Egbert M; Whitty A
Curr Opin Chem Biol; 2018 Jun; 44():1-8. PubMed ID: 29800865
[TBL] [Abstract][Full Text] [Related]
11. From drug target to leads--sketching a physicochemical pathway for lead molecule design in silico.
Shaikh SA; Jain T; Sandhu G; Latha N; Jayaram B
Curr Pharm Des; 2007; 13(34):3454-70. PubMed ID: 18220783
[TBL] [Abstract][Full Text] [Related]
12. Development of a rule-based method for the assessment of protein druggability.
Perola E; Herman L; Weiss J
J Chem Inf Model; 2012 Apr; 52(4):1027-38. PubMed ID: 22448735
[TBL] [Abstract][Full Text] [Related]
13. Molecular fields in ligand discovery.
Gane PJ; Chan AW
Methods Mol Biol; 2013; 1008():479-99. PubMed ID: 23729264
[TBL] [Abstract][Full Text] [Related]
14. Structure-based design of small-molecule protein-protein interaction modulators: the story so far.
Falchi F; Caporuscio F; Recanatini M
Future Med Chem; 2014 Mar; 6(3):343-57. PubMed ID: 24575969
[TBL] [Abstract][Full Text] [Related]
15. Structure-Based Virtual Screening of Commercially Available Compound Libraries.
Kireev D
Methods Mol Biol; 2016; 1439():65-76. PubMed ID: 27316988
[TBL] [Abstract][Full Text] [Related]
16. Ligand-biased ensemble receptor docking (LigBEnD): a hybrid ligand/receptor structure-based approach.
Lam PC; Abagyan R; Totrov M
J Comput Aided Mol Des; 2018 Jan; 32(1):187-198. PubMed ID: 28887659
[TBL] [Abstract][Full Text] [Related]
17. The SGC beyond structural genomics: redefining the role of 3D structures by coupling genomic stratification with fragment-based discovery.
Bradley AR; Echalier A; Fairhead M; Strain-Damerell C; Brennan P; Bullock AN; Burgess-Brown NA; Carpenter EP; Gileadi O; Marsden BD; Lee WH; Yue W; Bountra C; von Delft F
Essays Biochem; 2017 Nov; 61(5):495-503. PubMed ID: 29118096
[TBL] [Abstract][Full Text] [Related]
18. Template-Based Method for Conformation Generation and Scoring for Congeneric Series of Ligands.
Raman EP
J Chem Inf Model; 2019 Jun; 59(6):2690-2701. PubMed ID: 31045363
[TBL] [Abstract][Full Text] [Related]
19. The interplay between molecular modeling and chemoinformatics to characterize protein-ligand and protein-protein interactions landscapes for drug discovery.
Medina-Franco JL; Méndez-Lucio O; Martinez-Mayorga K
Adv Protein Chem Struct Biol; 2014; 96():1-37. PubMed ID: 25443953
[TBL] [Abstract][Full Text] [Related]
20. Protein binding site analysis for drug discovery using a computational fragment-based method.
Ludington JL
Methods Mol Biol; 2015; 1289():145-54. PubMed ID: 25709039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
